Sortases are cell-membrane-anchored cysteine transpeptidases that are essential for the assembly and anchoring of cell-surface adhesins in Gram-positive bacteria. Thus, they play critical roles in virulence, infection and colonization by pathogens. Sortases have been classified into four types based on their primary sequence and the target-protein motifs that they recognize. All Gram-positive bacteria express a class A housekeeping sortase (SrtA). Sortase A from Streptococcus pneumoniae (NP_358691) has been crystallized in two crystal forms. Diamond-shaped crystals of ÁN 59 SrtA diffracted to 4.0 Å resolution and belonged to a tetragonal system with unit-cell parameters a = b = 122.8, c = 86.5 Å , = = = 90 , while rod-shaped crystals of ÁN 81 SrtA diffracted to 2.91 Å resolution and belonged to the monoclinic space group P2 1 with unit-cell parameters a = 66.8, b = 103.47, c = 74.79 Å , = = 90, = 115.65 . The Matthews coefficient (V M = 2.77 Å 3 Da À1 ) with $56% solvent content suggested the presence of four molecules in the asymmetric unit for ÁN 81 SrtA. Also, a multi-copy search using a monomer as a probe in the molecular-replacement method resulted in the successful location of four sortase molecules in the asymmetric unit, with statistics R = 41.61, R free = 46.44, correlation coefficient (CC) = 64.31, CC free = 57.67.
Introduction
Pneumococcal diseases caused by Streptococcus pneumoniae lead to approximately 1.6 million deaths annually, including those of one million children under the age of five (Levine et al., 2006) . The increasing prevalence of antibiotic-resistant strains necessitates the development of novel therapeutics. Sortase A (EC 3.4.22.70) is an attractive drug target because it is present in all Gram-positive bacteria (Cossart & Jonquiè res, 2000) and there are no sortaserelated homologues in eukaryotes. Sortase A is important for cellsurface anchoring of several virulence proteins to the bacterial cell-wall peptidoglycan (Hendrickx et al., 2011) . Sortase A substrates are characterized by the presence of a C-terminal cell-wall-sorting signal, which comprises of a sortase-recognition motif LPXTG followed by a stretch of hydrophobic residues and a positively charged tail (Schneewind et al., 1993) . Knocking out sortase impacts pathogenesis but has no effect on viability. Therefore, inhibition of sortase would reduce the selection pressure towards the development of drug resistance (Mazmanian et al., 1999) . The presence of sortase in the cell membrane rather than inside the cell makes it easily accessible to inhibitors (Clancy et al., 2010) . Additionally, sortases have important biotechnological applications (Samantaray et al., 2008; Proft, 2010) . To date, crystal structures of sortase A from Staphylococcus aureus (Zong et al., 2004) and from Streptococcus pyogenes (Race et al., 2009 ) have been determined. Sortase A from both these organisms adopts an eight-stranded -barrel structure. The overall fold is conserved among the sortase isoforms, with some modifications (Clancy et al., 2010) . This paper reports the crystallization and preliminary structural analysis of sortase A from Streptococcus pneumoniae. The full-length S. pneumoniae sortase A is more closely related to S. pyogenes sortase A than to S. aureus sortase A in terms of sequence identity (63% versus 28% for sequence-alignment lengths of 166 and 118, respectively). The structure of the protein would aid in the under-standing of its mechanism of catalysis and substrate recognition and eventually in the design of structure-based inhibitors.
Materials and methods
2.1. Cloning, expression and purification of sortase A There are intrinsic difficulties in the expression and purification of full-length sortases because they are membrane-anchored proteins. Deletion of the transmembrane region at the N-terminus facilitates the expression of soluble protein (Ilangovan et al., 2001) . The DNA encoding residues 60-247 of S. pneumoniae sortase A (ÁN 59 SrtA), analogous to the S. aureus ÁN 59 SrtA construct, was amplified from genomic DNA of S. pneumoniae strain R6 by PCR using gene-specific primers. The amplified fragment was digested with NdeI and HindIII and cloned into a pET28c expression vector. The vector adds an N-terminal hexahistidine tag (MGSSHHHHHHSSGLVPRSHM) to the expressed protein. The pET28c-ÁN 59 SrtA construct was transformed into Escherichia coli BL21 (DE3) cells for overexpression of the recombinant protein. The cells were grown at 310 K until the OD 600 reached 0.6; they were then induced with 0.5 mM IPTG and grown for a further 5 h at 303 K prior to harvesting. The harvested cells were resuspended in buffer R (10 mM Tris pH 7.5, 40 mM NaCl, 2 mM -mercaptoethanol) and lysed by sonication. The cell lysate was centrifuged at 12 000 rev min À1 for 30 min and the resulting supernatant was loaded onto an Ni-NTA agarose column which had been equilibrated with five column volumes of buffer R. Upon binding of the recombinant protein to the Ni-NTA agarose, the column was washed with ten column volumes of a buffer consisting of 10 mM Tris pH 7.5, 30 mM imidazole, 500 mM NaCl and 2 mM -mercaptoethanol. The His-tagged protein was eluted with five column volumes of buffer R containing 250 mM imidazole. The eluted protein was concentrated using Millipore Amicon filters (10 kDa molecular-weight cutoff) and loaded onto a PD-10 column (GE Healthcare, USA) for desalting. The purified protein was analyzed on SDS-PAGE.
The S. pneumoniae ÁN 81 SrtA construct (residues 82-247), which is analogous to the S. pyogenes ÁN 81 SrtA construct, was subcloned from the pET28c-ÁN 59 SrtA construct into pET28c vector. The pET28c-ÁN 81 SrtA construct was transformed into E. coli BL21 (DE3) cells. The S. pneumoniae ÁN 81 SrtA protein was purified using the same protocol as followed for S. pneumoniae ÁN 59 SrtA.
Crystallization
Initial screening for crystallization conditions for the ÁN 59 SrtA protein construct ($23 kDa) was performed using commercially available crystallization solutions. The conditions were examined using the hanging-drop method at 293 K; the drop (4 ml) consisted of 2 ml protein solution (5-15 mg ml À1 in 10 mM Tris buffer pH 7.5) and 2 ml reservoir solution. The ÁN 59 SrtA construct containing an N-terminal His tag crystallized as diamond-, needle-, rod-and wedgeshaped crystal forms (Fig. 1 ) in more than one crystallization condition within two to four weeks. The crystals grew to their maximum size in a month. However, these crystals did not diffract either at the home source or the synchrotron.
crystallization communications
In another attempt at crystallization, trials were set up in microbatch plates at 293 K using 2 ml protein sample (6 mg ml À1 in 10 mM Tris buffer pH 7.5) and 2 ml crystallization condition under a 1:1 mixture of silicon oil and paraffin oil. Diamond-shaped crystals again appeared within two weeks in a solution consisting of 1.1 M sodium malonate and 0.1 M HEPES pH 7.0. These crystals ( Fig. 2a ) diffracted to 4.0 Å resolution at the home source.
Subsequently, we made modifications to the SrtA construct in order to improve the diffraction quality of the crystals. For further crystallization experiments, we used the new construct ÁN 81 SrtA, containing an N-terminal His tag, which gave well diffracting rodshaped crystals at a protein concentration of 25 mg ml À1 (in 10 mM Tris buffer pH 7.5) with a solution of 0.2 M tri-ammonium citrate and 20%(w/v) PEG 3350 pH 7.0 using the microbatch-under-oil crystallization method (Fig. 2b) .
Data collection and processing
Crystals suitable for data collection were flash-cooled in liquid nitrogen. Data were collected from diamond-shaped ÁN 59 SrtA crystals of dimensions $0.2 Â 0.2 Â 0.1 mm and rod-shaped ÁN 81 SrtA crystals of dimensions $0.5 Â 0.1 Â 0.05 mm at 100 K (Oxford Cryosystems) using a MAR imaging-plate system (diameter 345 mm) mounted on a Bruker Microstar Ultra 2 rotating-anode generator (Cu K radiation; = 1.5418 Å ). Crystals of the ÁN 59 SrtA construct diffracted to 4.0 Å resolution (data not presented). None of the known cryoprotectants were found to improve the diffraction quality. Crystals of the modified construct ÁN 81 SrtA diffracted to 2.91 Å resolution without using any external cryoprotectant apart from the 20% PEG 3350 present in the crystallization condition (Fig. 3) . A total of 408 frames were collected with 5 min exposure per frame, 0.5 oscillation and a crystal-to-detector distance of 180 mm.
The intensity data were processed using MOSFLM (Leslie, 2006 ) and were scaled using the program SCALA (Evans, 1993) from the CCP4 program suite (Winn et al., 2011) . Structure-factor amplitudes were obtained from intensities using TRUNCATE (French & Wilson, 1978) from the CCP4 suite. Data-collection and processing statistics for the ÁN 81 SrtA crystal are presented in Table 1 .
Results and discussion
Diamond-shaped crystals of ÁN 59 SrtA appeared two to four weeks after setting up crystallization experiments using the microbatchunder-oil method. These crystals ( Fig. 2a ) had dimensions of $0.2 Â 0.2 Â 0.1 mm and diffracted to 4.0 Å resolution. The ÁN 59 SrtA crystals belonged to the tetragonal system, with unit-cell parameters a = b = 122.8, c = 86.5 Å , = = = 90 . To overcome the poor diffraction quality of the crystals obtained using this construct, we crystallized the construct ÁN 81 SrtA with a rod-shaped crystal morphology with approximate dimensions of 0.5 Â 0.1 Â 0.05 mm; the crystals belonged to the monoclinic space group P2 1 (Fig. 2b) only crystallized with a rod-like morphology, whereas ÁN 59 SrtA crystallized with four different morphologies. The data-collection statistics for the rod-shaped ÁN 81 SrtA crystal are reported in Table 1 and a diffraction pattern is shown in Fig. 3 . Based on the molecular weight and the space group, it was inferred that there were four molecules of ÁN 81 SrtA in the asymmetric unit of the crystal, which corresponds to a solvent content of about 56% (Matthews, 1968) . Initial molecular-replacement trials were performed in Phaser (Read, 2001; Storoni et al., 2004) using the sortase A protein from S. pyogenes (PDB entry 3fn5; Race et al., 2009) , which has 64% sequence identity over 164 residues, as a search model. The best solution using Phaser (TFZ score = 7.5, LLG score = 930), as well as the initial R and R free after the first refinement cycle (41.61 and 46.44, respectively, with correlation coefficients CC = 64.31 and CC free = 57.67), supports the presence of four sortase subunits in the asymmetric unit. These four molecules are arranged tetrahedrally (Katre & Suresh, 2009 ) and can also be described as a dimer of dimers oriented nearly perpendicular to each other at their ends. In this regard, it is pertinent to note that the prototypical sortase A from S. aureus displays a strong tendency to form oligomers and exists predominantly as a dimer (Lu et al., 2007) . The dimeric enzyme shows enhanced catalytic activity. It is conceivable that S. pneumoniae sortase A (ÁN 81 SrtA) is also endowed with similar attributes. Crystal structure determination of ÁN 81 SrtA is in progress. The determined structure is likely to shed light on sortase catalysis as well as to help in the structure-based design of sortase inhibitors. 
